Quarterly ResultMay 13, 2026, 04:27 PM
Health In Tech Q1 Revenue +9.4% to $8.8M; Net Loss $(1.6)M
AI Summary
Health In Tech reported its first quarter 2026 financial results, with revenue increasing 9.4% to $8.8 million. However, the company posted a net loss of $1.6 million, or $(0.03) per diluted share, and Adjusted EBITDA of $(1.3) million, primarily due to increased sales and marketing investments for long-term growth. The company reiterated its full-year 2026 revenue guidance of $45 million to $50 million, citing strong demand for its AI-enabled platform and successful deployment of new features. Health In Tech also highlighted growth in distribution partners and a recent private investment in public equity financing to fund expansion initiatives.
Key Highlights
- Revenue increased 9.4% to $8.8 million in Q1 2026 from $8.0 million in Q1 2025.
- Net loss totaled $1.6 million, or $(0.03) per diluted share, compared to net income of $0.5 million, or $0.01 per diluted share, in Q1 2025.
- Adjusted EBITDA was $(1.3) million, down from $1.2 million in Q1 2025, due to higher sales and marketing expenses.
- Distribution partners grew 29.5% to 896 as of March 31, 2026, up from 692 a year prior.
- Cash and cash equivalents totaled $10.3 million as of March 31, 2026, up from $7.6 million as of March 31, 2025.
- Working capital increased to $15.0 million as of March 31, 2026, from $8.8 million a year ago.
- Reiterated 2026 annual revenue guidance between $45 million and $50 million, representing 35% to 50% year-over-year growth.
- Contracted revenue for the remaining three quarters of 2026 equaled $22.9 million.